Certara (MEX:CERT) Stock Based Compensation: MXN610 Mil (TTM As of Mar. 2026)


MEX:CERT Certara Inc MEX:CERT
65 GF Score
Price MXN254.00
GF Value MXN487.96
! 2 Warning Signs
View Full Analysis

What is Certara Stock Based Compensation?

Certara MEX:CERT 65 Stock Based Compensation is MXN610 Mil as of Mar. 2026. GuruFocus rates MEX:CERT with a GF Score™ of 65/100 and a GF Value™ of MXN487.96. The stock has 2 warning signs investors should review.

Certara's Stock Based Compensation for the three months ended in Mar. 2026 was MXN132 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was MXN610 Mil.

Certara Stock Based Compensation Related Terms

Certara Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Certara's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Certara Stock Based Compensation Chart

Certara Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial 604.81 591.61 480.37 725.24 595.61

Certara Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 144.64 155.25 175.63 147.47 132.00
MEX:CERT
65GF Score
Certara Inc MEX:CERT
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Certara Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN610 Mil.

What does a Stock Based Compensation of MXN610 Mil mean?
Certara (MEX:CERT) has a Stock Based Compensation of MXN610 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Certara and its competitors.
Is Certara's Stock Based Compensation too high?
Certara's current Stock Based Compensation is MXN610 Mil. Overall, Certara has a GF Score™ of 65/100, reflecting its overall financial health beyond just this single metric.
How does Certara's Stock Based Compensation compare to TALK and GDRX?
Certara's Stock Based Compensation of MXN610 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Healthcare Providers & Services company?
A good Stock Based Compensation depends on the Healthcare Providers & Services industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Certara and its competitors. Certara's current Stock Based Compensation is MXN610 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Certara stock overvalued right now?
Certara (MEX:CERT) has a current Stock Based Compensation of MXN610 Mil. The stock's GF Value™ is MXN487.96, compared to a current price of MXN254.00 — trading 47.9% below its estimated fair value. The current Stock Based Compensation is MXN610 Mil. Certara's overall GF Score™ is 65/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Certara (MEX:CERT), the current Stock Based Compensation is MXN610 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Certara (MEX:CERT) Overvalued in 2026?

Based on GuruFocus' analysis, Certara stock appears to be undervalued. The current stock price of MXN254.00 is trading 47.9% below its estimated GF Value™ of MXN487.96.

Key valuation signals for MEX:CERT:

  • Stock Based Compensation: MXN610 Mil
  • GF Value™: MXN487.96 vs. price of MXN254.00 (47.9% below fair value)
  • GF Score™: 65/100 with 2 warning signs

No single metric tells the full story. See the MEX:CERT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Certara Business Description

Other Exchanges CERT:USA
Address 4 Radnor Corporate Center, Suite 350, Radnor, PA, USA, 19087
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.
65GF Score

Get the complete analysis for MEX:CERT

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN254.00
Price
MXN487.96
GF Value